Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Sep 17, 2026, 4:10 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 30.99 million as of September 18, 2026. Its market cap has increased by 13.75% in one year.
Market Cap
30.99M
Enterprise Value
160.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 30.99M, an increase of 35.07%. That is a compound annual growth rate of 1.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 30.99M | 7.76% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 39.23M |
| Telescope Innovations | 37.18M |
| Defence Therapeutics | 37.14M |
| Thiogenesis Therapeutics | 35.69M |
| The More Life Company | 29.71M |
| Pharmala Biotech Holdings | 29.07M |
| Onco-Innovations | 27.69M |